These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 8752157

  • 1. Protease inhibitors induce specific changes in protein tyrosine phosphorylation that correlate with inhibition of apoptosis in myeloid cells.
    Lumelsky NL, Schwartz BS.
    Cancer Res; 1996 Sep 01; 56(17):3909-14. PubMed ID: 8752157
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
    Bertrand R, Solary E, Jenkins J, Pommier Y.
    Exp Cell Res; 1993 Aug 01; 207(2):388-97. PubMed ID: 7688316
    [Abstract] [Full Text] [Related]

  • 3. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells.
    Huang Y, Sheikh MS, Fornace AJ, Holbrook NJ.
    Oncogene; 1999 Jun 10; 18(23):3431-9. PubMed ID: 10376521
    [Abstract] [Full Text] [Related]

  • 4. DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studies.
    Shimizu T, Pommier Y.
    Exp Cell Res; 1996 Aug 01; 226(2):292-301. PubMed ID: 8806433
    [Abstract] [Full Text] [Related]

  • 5. [Analysis of drug-induced apoptosis in human leukemic cell line (HL-60)].
    Hara S, Tagawa Y, Ayabe H, Darzynkiwicz Z.
    Gan To Kagaku Ryoho; 1998 Apr 01; 25 Suppl 3():393-9. PubMed ID: 9589041
    [Abstract] [Full Text] [Related]

  • 6. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities.
    Schmitt E, Cimoli G, Steyaert A, Bertrand R.
    Exp Cell Res; 1998 Apr 10; 240(1):107-21. PubMed ID: 9570926
    [Abstract] [Full Text] [Related]

  • 7. Caspase I-related protease inhibition retards the execution of okadaic acid- and camptothecin-induced apoptosis and PAI-2 cleavage, but not commitment to cell death in HL-60 cells.
    Jensen PH, Fladmark KE, Gjertsen BT, Vintermyr OK.
    Br J Cancer; 1999 Apr 10; 79(11-12):1685-91. PubMed ID: 10206278
    [Abstract] [Full Text] [Related]

  • 8. Brefeldin A is a potent inducer of apoptosis in human cancer cells independently of p53.
    Shao RG, Shimizu T, Pommier Y.
    Exp Cell Res; 1996 Sep 15; 227(2):190-6. PubMed ID: 8831555
    [Abstract] [Full Text] [Related]

  • 9. The CrmA- and TPCK-sensitive pathways that trigger oligonucleosome-sized DNA fragmentation in camptothecin-induced apoptosis: relation to caspase activation and high molecular weight DNA fragmentation.
    Sané AT, Schmitt E, Steyaert A, Meyer D, Bertrand R.
    Biochem Cell Biol; 1997 Sep 15; 75(4):359-68. PubMed ID: 9493958
    [Abstract] [Full Text] [Related]

  • 10. Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities.
    Sané AT, Bertrand R.
    Cancer Res; 1998 Jul 15; 58(14):3066-72. PubMed ID: 9679972
    [Abstract] [Full Text] [Related]

  • 11. Role of serine and ICE-like proteases in induction of apoptosis by etoposide in human leukemia HL-60 cells.
    Yoshida A, Takauji R, Inuzuka M, Ueda T, Nakamura T.
    Leukemia; 1996 May 15; 10(5):821-4. PubMed ID: 8656677
    [Abstract] [Full Text] [Related]

  • 12. Bcl-2-mediated resistance to apoptosis is associated with glutathione-induced inhibition of AP24 activation of nuclear DNA fragmentation.
    Wright SC, Wang H, Wei QS, Kinder DH, Larrick JW.
    Cancer Res; 1998 Dec 01; 58(23):5570-6. PubMed ID: 9850096
    [Abstract] [Full Text] [Related]

  • 13. Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate.
    An B, Dou QP.
    Cancer Res; 1996 Feb 01; 56(3):438-42. PubMed ID: 8564948
    [Abstract] [Full Text] [Related]

  • 14. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.
    Jarvis WD, Turner AJ, Povirk LF, Traylor RS, Grant S.
    Cancer Res; 1994 Apr 01; 54(7):1707-14. PubMed ID: 7511048
    [Abstract] [Full Text] [Related]

  • 15. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
    Eymin B, Dubrez L, Allouche M, Solary E.
    Cancer Res; 1997 Feb 15; 57(4):686-95. PubMed ID: 9044846
    [Abstract] [Full Text] [Related]

  • 16. Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death.
    Sané AT, Bertrand R.
    Cancer Res; 1999 Aug 01; 59(15):3565-9. PubMed ID: 10446962
    [Abstract] [Full Text] [Related]

  • 17. Lamin B phosphorylation by protein kinase calpha and proteolysis during apoptosis in human leukemia HL60 cells.
    Shimizu T, Cao CX, Shao RG, Pommier Y.
    J Biol Chem; 1998 Apr 10; 273(15):8669-74. PubMed ID: 9535842
    [Abstract] [Full Text] [Related]

  • 18. Topoisomerase I inhibitor, camptothecin, induces apoptogenic signaling in human embryonic stem cells.
    García CP, Videla Richardson GA, Romorini L, Miriuka SG, Sevlever GE, Scassa ME.
    Stem Cell Res; 2014 Mar 10; 12(2):400-14. PubMed ID: 24380814
    [Abstract] [Full Text] [Related]

  • 19. The pro-apoptotic drug camptothecin stimulates phospholipase D activity and diacylglycerol production in the nucleus of HL-60 human promyelocytic leukemia cells.
    Martelli AM, Bortul R, Bareggi R, Tabellini G, Grill V, Baldini G, Narducci P.
    Cancer Res; 1999 Aug 15; 59(16):3961-7. PubMed ID: 10463592
    [Abstract] [Full Text] [Related]

  • 20. Resistance to apoptosis induced by topoisomerase I inhibitors in multidrug-resistant HL60 leukemic cells.
    Palissot V, Belhoussine R, Carpentier Y, Sebille S, Morjani H, Manfait M, Dufer J.
    Biochem Biophys Res Commun; 1998 Apr 28; 245(3):918-22. PubMed ID: 9588215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.